《经济学人》：药企延寿疗法此前屡屡失败，新一波生物科技创始人押注这次不同
Previous efforts by drugmakers to create longevity treatments have ended in disappointment. A new wave of biotech founders and investors argue that th...
AI 导读
《经济学人》报道，药企此前研发抗衰老（延寿）疗法的努力均以失望告终，新一波生物科技创始人和投资者认为这次情况将有所不同。
来源：@TheEconomist · x.com